Arpraziquantel

Arpraziquantel
Clinical data
Other names	(R)-Praziquantel
Drug class	Anthelmintic
ATC code	P02BA03 (WHO) ;
Identifiers
CAS Number	57452-98-9;
PubChem CID	445900;
DrugBank	DB11749;
ChemSpider	393394;
UNII	WF15T5925V;
KEGG	D12741;
ChEMBL	ChEMBL1235551;
PDB ligand	PZQ (PDBe, RCSB PDB);
CompTox Dashboard (EPA)	DTXSID80904739 ;
Chemical and physical data
Formula	C19H24N2O2
Molar mass	312.413 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES [H][C@@]12CN(CC(=O)N1CCC1=CC=CC=C21)C(=O)C1CCCCC1;
	InChI InChI=1S/C19H24N2O2/c22-18-13-20(19(23)15-7-2-1-3-8-15)12-17-16-9-5-4-6-14(16)10-11-21(17)18/h4-6,9,15,17H,1-3,7-8,10-13H2/t17-/m0/s1; Key:FSVJFNAIGNNGKK-KRWDZBQOSA-N;

Other names(R)-Praziquantel

Arpraziquantel ((R)-praziquantel) is the eutomer (the biologically active enantiomer) of praziquantel, and is a medication which is currently under investigation for the treatment of schistosomiasis in young children since it has less side effects than the usual racemic mixture formulation of praziquantel.^[1]

Legal status